{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T04:57:40Z","timestamp":1764133060408},"reference-count":59,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.3892\/ol.2017.6672","type":"journal-article","created":{"date-parts":[[2017,7,26]],"date-time":"2017-07-26T13:07:40Z","timestamp":1501074460000},"page":"4372-4378","source":"Crossref","is-referenced-by-count":7,"title":["Recurrent alterations of the WW domain containing oxidoreductase gene spanning the common fragile site FRA16D in multiple myeloma and monoclonal gammopathy of undetermined significance"],"prefix":"10.3892","volume":"14","author":[{"given":"Hiroshi","family":"Handa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiko","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hikaru","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lobna","family":"Alkebsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuhiro","family":"Kasamatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Saitoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeki","family":"Mitsui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Yokohama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norifumi","family":"Tsukamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morio","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2017,7,26]]},"reference":[{"key":"key20180108114833_b1-ol-0-0-6672","doi-asserted-by":"crossref","first-page":"5611","DOI":"10.1038\/sj.onc.1204641","article-title":"Chromosome translocations in multiple myeloma","volume":"20","author":"Bergsagel","year":"2001","journal-title":"Oncogene"},{"key":"key20180108114833_b2-ol-0-0-6672","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s12185-013-1291-2","article-title":"Molecular pathogenesis of multiple myeloma: Basic and clinical updates","volume":"97","author":"Chesi","year":"2013","journal-title":"Int J Hematol"},{"key":"key20180108114833_b3-ol-0-0-6672","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nrc3257","article-title":"The genetic architecture of multiple myeloma","volume":"12","author":"Morgan","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"key20180108114833_b4-ol-0-0-6672","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1182\/blood-2012-01-405977","article-title":"Whole-genome sequencing of multiple myeloma from diagnosis to plasma cell leukemia reveals genomic initiating events, evolution, and clonal tides","volume":"120","author":"Egan","year":"2012","journal-title":"Blood"},{"key":"key20180108114833_b5-ol-0-0-6672","first-page":"999","article-title":"Multiple myeloma: 2014 Update on diagnosis, risk-stratification and management","volume":"89","author":"Vincent","year":"2014","journal-title":"Am J Hematol"},{"key":"key20180108114833_b6-ol-0-0-6672","doi-asserted-by":"crossref","first-page":"326","DOI":"10.2174\/138920210791616699","article-title":"DNA instability at chromosomal fragile sites in cancer","volume":"11","author":"Dillon","year":"2010","journal-title":"Curr Genomics"},{"key":"key20180108114833_b7-ol-0-0-6672","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.canlet.2005.08.032","article-title":"Common fragile sites","volume":"232","author":"Glover","year":"2006","journal-title":"Cancer Lett"},{"key":"key20180108114833_b8-ol-0-0-6672","doi-asserted-by":"crossref","first-page":"4601","DOI":"10.1007\/s00018-014-1753-6","article-title":"Very large common fragile site genes and their potential role in cancer development","volume":"71","author":"Gao","year":"2014","journal-title":"Cell Mol Life Sci"},{"key":"key20180108114833_b9-ol-0-0-6672","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.tig.2011.10.003","article-title":"Common fragile sites: Mechanisms of instability revisited","volume":"28","author":"Debatisse","year":"2012","journal-title":"Trends Genet"},{"key":"key20180108114833_b10-ol-0-0-6672","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0959-437X(95)80046-8","article-title":"The molecular basis of fragile sites in human chromosomes","volume":"5","author":"Sutherland","year":"1995","journal-title":"Curr Opin Genet Dev"},{"key":"key20180108114833_b11-ol-0-0-6672","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/1098-2264(2000)9999:9999<::AID-GCC1083>3.0.CO;2-M","article-title":"Human hepatocellular carcinoma is characterized by a highly consistent pattern of genomic imbalances, including frequent loss of 16q23.1-24.1","volume":"30","author":"Balsara","year":"2001","journal-title":"Genes Chromosomes Cancer"},{"key":"key20180108114833_b12-ol-0-0-6672","first-page":"3645","article-title":"Identification and fine mapping of a region showing a high frequency of allelic imbalance on chromosome 16q23.2 that corresponds to a prostate cancer susceptibility locus","volume":"60","author":"Paris","year":"2000","journal-title":"Cancer Res"},{"key":"key20180108114833_b13-ol-0-0-6672","first-page":"2166","article-title":"Allelic loss of 16q23.2-24.2 is an independent marker of good prognosis in primary breast cancer","volume":"58","author":"Hansen","year":"1998","journal-title":"Cancer Res"},{"key":"key20180108114833_b14-ol-0-0-6672","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.canlet.2005.07.041","article-title":"Common chromosomal fragile sites and cancer: Focus on FRA16D","volume":"232","author":"O'Keefe","year":"2006","journal-title":"Cancer Lett"},{"key":"key20180108114833_b15-ol-0-0-6672","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1093\/hmg\/9.11.1651","article-title":"Common chromosomal fragile site FRA16D sequence: Identification of the FOR gene spanning FRA16D and homozygous deletions and translocation breakpoints in cancer cells","volume":"9","author":"Ried","year":"2000","journal-title":"Hum Mol Genet"},{"key":"key20180108114833_b16-ol-0-0-6672","first-page":"2140","article-title":"WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer","volume":"60","author":"Bednarek","year":"2000","journal-title":"Cancer Res"},{"key":"key20180108114833_b17-ol-0-0-6672","doi-asserted-by":"crossref","first-page":"11417","DOI":"10.1073\/pnas.191175898","article-title":"WWOX: A candidate tumor suppressor gene involved in multiple tumor types","volume":"98","author":"Paige","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180108114833_b18-ol-0-0-6672","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000072844","article-title":"WWOX, the common chromosomal fragile site, FRA16D, cancer gene","volume":"100","author":"Ludes-Meyers","year":"2003","journal-title":"Cytogenet Genome Res"},{"key":"key20180108114833_b19-ol-0-0-6672","first-page":"1690","article-title":"A 700-kb physical map of a region of 16q23.2 homozygously deleted in multiple cancers and spanning the common fragile site FRA16D","volume":"60","author":"Paige","year":"2000","journal-title":"Cancer Res"},{"key":"key20180108114833_b20-ol-0-0-6672","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/gcc.20548","article-title":"Homozygous deletions may be markers of nearby heterozygous mutations: The complex deletion at FRA16D in the HCT116 colon cancer cell line removes exons of WWOX","volume":"47","author":"Alsop","year":"2008","journal-title":"Genes Chromosomes Cancer"},{"key":"key20180108114833_b21-ol-0-0-6672","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/nature08822","article-title":"The landscape of somatic copy-number alteration across human cancers","volume":"463","author":"Beroukhim","year":"2010","journal-title":"Nature"},{"key":"key20180108114833_b22-ol-0-0-6672","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/nature08768","article-title":"Signatures of mutation and selection in the cancer genome","volume":"463","author":"Bignell","year":"2010","journal-title":"Nature"},{"key":"key20180108114833_b23-ol-0-0-6672","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1006\/geno.2000.6321","article-title":"The characterization of the common fragile site FRA16D and its involvement in multiple myeloma translocations","volume":"69","author":"Krummel","year":"2000","journal-title":"Genomics"},{"key":"key20180108114833_b24-ol-0-0-6672","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1182\/blood-2007-02-075069","article-title":"Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myeloma","volume":"110","author":"Jenner","year":"2007","journal-title":"Blood"},{"key":"key20180108114833_b25-ol-0-0-6672","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/gcc.20668","article-title":"A SNP microarray and FISH-based procedure to detect allelic imbalances in multiple myeloma: An integrated genomics approach reveals a wide gene dosage effect","volume":"48","author":"Agnelli","year":"2009","journal-title":"Genes Chromosomes Cancer"},{"key":"key20180108114833_b26-ol-0-0-6672","first-page":"8068","article-title":"WWOX, the FRA16D gene, behaves as a suppressor of tumor growth","volume":"61","author":"Bednarek","year":"2001","journal-title":"Cancer Res"},{"key":"key20180108114833_b27-ol-0-0-6672","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1038\/sj.onc.1205273","article-title":"Alternative transcripts of the candidate tumor suppressor gene, WWOX, are expressed at high levels in human breast tumors","volume":"21","author":"Driouch","year":"2002","journal-title":"Oncogene"},{"key":"key20180108114833_b28-ol-0-0-6672","first-page":"1681","article-title":"WWOX mRNA expression profile in epithelial ovarian cancer supports the role of WWOX variant 1 as a tumour suppressor, although the role of variant 4 remains unclear","volume":"26","author":"Gourley","year":"2005","journal-title":"Int J Oncol"},{"key":"key20180108114833_b29-ol-0-0-6672","first-page":"878","article-title":"WW domain containing oxidoreductase gene expression is altered in non-small cell lung cancer","volume":"63","author":"Yendamuri","year":"2003","journal-title":"Cancer Res"},{"key":"key20180108114833_b30-ol-0-0-6672","first-page":"2258","article-title":"Genetic alterations of the tumor suppressor gene WWOX in esophageal squamous cell carcinoma","volume":"62","author":"Kuroki","year":"2002","journal-title":"Cancer Res"},{"key":"key20180108114833_b31-ol-0-0-6672","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1038\/sj.onc.1208398","article-title":"Fragile genes as biomarkers: Epigenetic control of WWOX and FHIT in lung, breast and bladder cancer","volume":"24","author":"Iliopoulos","year":"2005","journal-title":"Oncogene"},{"key":"key20180108114833_b32-ol-0-0-6672","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1158\/1078-0432.CCR-06-2038","article-title":"Inhibition of breast cancer cell growth in vitro and in vivo: Effect of restoration of Wwox expression","volume":"13","author":"Iliopoulos","year":"2007","journal-title":"Clin Cancer Res"},{"key":"key20180108114833_b33-ol-0-0-6672","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/ijc.22073","article-title":"Epigenetic modulation of endogenous tumor suppressor expression in lung cancer xenografts suppresses tumorigenicity","volume":"120","author":"Cantor","year":"2007","journal-title":"Int J Cancer"},{"key":"key20180108114833_b34-ol-0-0-6672","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1182\/blood.V89.7.2500","article-title":"Frequent hypermethylation of p16 and p15 genes in multiple myeloma","volume":"89","author":"Ng","year":"1997","journal-title":"Blood"},{"key":"key20180108114833_b35-ol-0-0-6672","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1182\/blood.V98.1.244","article-title":"p16 (INK4a) and p15 (INK4b) gene methylations in plasma cells from monoclonal gammopathy of undetermined significance","volume":"98","author":"Guillerm","year":"2001","journal-title":"Blood"},{"key":"key20180108114833_b36-ol-0-0-6672","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00277-009-0818-3","article-title":"DNA methylation analysis of tumor suppressor genes in monoclonal gammopathy of undetermined significance","volume":"89","author":"Stanganelli","year":"2010","journal-title":"Ann Hematol"},{"key":"key20180108114833_b37-ol-0-0-6672","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s12185-009-0459-2","article-title":"Methylation status of nine tumor suppressor genes in multiple myeloma","volume":"91","author":"Braggio","year":"2010","journal-title":"Int J Hematol"},{"key":"key20180108114833_b38-ol-0-0-6672","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/sj.leu.2401617","article-title":"De novo methylation of tumor suppressor gene p16\/INK4a is a frequent finding in multiple myeloma patients at diagnosis","volume":"14","author":"Gonzalez","year":"2000","journal-title":"Leukemia"},{"key":"key20180108114833_b39-ol-0-0-6672","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.4049\/jimmunol.1202493","article-title":"Myeloma is characterized by stage-specific alterations in DNA methylation that occur early during myelomagenesis","volume":"190","author":"Heuck","year":"2013","journal-title":"J Immunol"},{"key":"key20180108114833_b40-ol-0-0-6672","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/blood-2013-03-487884","article-title":"Global methylation analysis identifies prognostically important epigenetically inactivated tumor suppressor genes in multiple myeloma","volume":"122","author":"Kaiser","year":"2013","journal-title":"Blood"},{"key":"key20180108114833_b41-ol-0-0-6672","first-page":"3429","article-title":"Methylation of the 5\u2032 CpG island of the FHIT gene is closely associated with transcriptional inactivation in esophageal squamous cell carcinomas","volume":"58","author":"Tanaka","year":"1998","journal-title":"Cancer Res"},{"key":"key20180108114833_b42-ol-0-0-6672","first-page":"3581","article-title":"5\u2032 CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer","volume":"61","author":"Z\u00f6chbauer-M\u00fcller","year":"2001","journal-title":"Cancer Res"},{"key":"key20180108114833_b43-ol-0-0-6672","first-page":"940","article-title":"Expression of FRA16D\/WWOX and FRA3B\/FHIT genes in hematopoietic malignancies","volume":"1","author":"Ishii","year":"2003","journal-title":"Mol Cancer Res"},{"key":"key20180108114833_b44-ol-0-0-6672","first-page":"693","article-title":"Aberrant methylation in promoter-associated CpG islands of multiple genes in therapy-related leukemia","volume":"23","author":"Uehara","year":"2003","journal-title":"Int J Oncol"},{"key":"key20180108114833_b45-ol-0-0-6672","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1038\/sj.bjc.6604986","article-title":"Hypermethylation-mediated reduction of WWOX expression in intraductal papillary mucinous neoplasms of the pancreas","volume":"100","author":"Nakayama","year":"2009","journal-title":"Br J Cancer"},{"key":"key20180108114833_b46-ol-0-0-6672","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000197911","article-title":"Association between CpG island methylation of the WWOX gene and its expression in breast cancers","volume":"30","author":"Wang","year":"2009","journal-title":"Tumour Biol"},{"key":"key20180108114833_b47-ol-0-0-6672","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3892\/br.2013.86","article-title":"Methylation status of WWOX gene promoter CpG islands in epithelial ovarian cancer and its clinical significance","volume":"1","author":"Yan","year":"2013","journal-title":"Biomed Rep"},{"key":"key20180108114833_b48-ol-0-0-6672","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1365-2141.2003.04355.x","article-title":"International Myeloma Working Group: Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: A report of the International Myeloma Working Group","volume":"121","year":"2003","journal-title":"Br J Haematol"},{"key":"key20180108114833_b49-ol-0-0-6672","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1200\/JCO.2005.04.242","article-title":"International staging system for multiple myeloma","volume":"23","author":"Greipp","year":"2005","journal-title":"J Clin Oncol"},{"key":"key20180108114833_b50-ol-0-0-6672","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1007\/s00018-014-1720-2","article-title":"Updating the mechanisms of common fragile site instability: How to reconcile the different views?","volume":"71","author":"Le Tallec","year":"2014","journal-title":"Cell Mol Life Sci"},{"key":"key20180108114833_b51-ol-0-0-6672","doi-asserted-by":"crossref","first-page":"E4716","DOI":"10.1073\/pnas.1409252111","article-title":"WWOX, the common fragile site FRA16D gene product, regulates ATM activation and the DNA damage response","volume":"111","author":"Abu-Odeh","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180108114833_b52-ol-0-0-6672","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.4161\/cc.25951","article-title":"DNA repair pathways in human multiple myeloma: Role in oncogenesis and potential targets for treatment","volume":"12","author":"Gourzones-Dmitriev","year":"2013","journal-title":"Cell Cycle"},{"key":"key20180108114833_b53-ol-0-0-6672","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1073\/pnas.0609783104","article-title":"Targeted deletion of Wwox reveals a tumor suppressor function","volume":"104","author":"Aqeilan","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180108114833_b54-ol-0-0-6672","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/gcc.20497","article-title":"WWOX hypomorphic mice display a higher incidence of B-cell lymphomas and develop testicular atrophy","volume":"46","author":"Ludes-Meyers","year":"2007","journal-title":"Genes Chromosomes Cancer"},{"key":"key20180108114833_b55-ol-0-0-6672","doi-asserted-by":"crossref","first-page":"e7775","DOI":"10.1371\/journal.pone.0007775","article-title":"Generation and characterization of mice carrying a conditional allele of the Wwox tumor suppressor gene","volume":"4","author":"Ludes-Meyers","year":"2009","journal-title":"PloS One"},{"key":"key20180108114833_b56-ol-0-0-6672","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1038\/onc.2009.120","article-title":"Inhibition of the Wnt\/beta-catenin pathway by the WWOX tumor suppressor protein","volume":"28","author":"Bouteille","year":"2009","journal-title":"Oncogene"},{"key":"key20180108114833_b57-ol-0-0-6672","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1182\/blood-2010-08-303073","article-title":"The tumor suppressor gene WWOX links the canonical and noncanonical NF-\u03baB pathways in HTLV-I Tax-mediated tumorigenesis","volume":"117","author":"Fu","year":"2011","journal-title":"Blood"},{"key":"key20180108114833_b58-ol-0-0-6672","doi-asserted-by":"crossref","first-page":"e0115353","DOI":"10.1371\/journal.pone.0115353","article-title":"Epigenetic and genetic alterations affect the WWOX gene in head and neck squamous cell carcinoma","volume":"10","author":"Ekizoglu","year":"2015","journal-title":"PloS One"},{"key":"key20180108114833_b59-ol-0-0-6672","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/jgh.12722","article-title":"Association of downregulation of WWOX with poor prognosis in patients with intrahepatic cholangiocarcinoma after curative resection","volume":"30","author":"Huang","year":"2015","journal-title":"J Gastroenterol Hepatol"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","deposited":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T13:17:05Z","timestamp":1602595025000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2017.6672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,26]]},"references-count":59,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,7,26]]},"published-print":{"date-parts":[[2017,10]]}},"alternative-id":["10.3892\/ol.2017.6672"],"URL":"https:\/\/doi.org\/10.3892\/ol.2017.6672","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,26]]}}}